Introduction
Advances in neonatal care over the last few decades have resulted in improved survival of preterm infants even at very early gestational ages. 1 However, morbidity, neurological impairment, and decrements in intellectual and social performance are still prevalent and strongly associated with gestational age at birth. 2, 3 The situation becomes even more critical if prematurity is determined by the need to rescue the fetus from an unfavorable intrauterine environmenteas is the case in placental insufficiency. The outcome of these infants will not only depend on the degree of prematurity but also on the severity of fetal growth restriction (FGR). [4] [5] [6] Given that no targeted treatment exists for FGR, delivery is the only intervention that can prevent severe hypoxemia and acidosis, and eventually intrauterine death. Thus, optimal monitoring and timing of delivery remains crucial in the management of early-onset FGR. 7 The issue of timing of delivery had first been addressed by the Growth Restriction Intervention Trial, which reported on 587 babies. 8, 9 This study randomized women with compromised small babies to immediate delivery or expectant management, based on equipoise of the clinician regarding optimal management. Early reports indicated that an expectant policy (time to delivery 4.9 days) seemed associated with a more favorable neurodevelopmental outcome than immediate delivery (0.9 days). At school age, however, no difference was found between immediate or delayed delivery. 10 From this or other studies there is no clear evidence to support delayed above early delivery. 11 A significant limitation of the Growth Restriction Intervention Trial was that neither gestational limits nor clinical criteria for monitoring and timing of delivery were defined. The only entry criterion for the study was the clinician's uncertainty on whether to deliver or continue the pregnancy.
Monitoring early FGR and timing delivery has been undertaken in a variety of ways, including biophysical profile scoring 12 and umbilical artery (UA) Doppler, 13 although there is little evidence underlying the use of either technique. Different UA Doppler patterns identify different degrees of impaired placental function. Absent end-diastolic velocities (AED) or reversed enddiastolic velocities (RED) indicate impairment of the fetoplacental circulation and presage fetal deterioration.
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Longitudinal studies conducted on highrisk pregnancies have shown that the transition from AED to RED may be slow and gradual in early FGR, nevertheless, both AED and RED have been associated not only with increased fetal and neonatal mortality but also with a higher incidence of long-term neurological impairment when compared with FGR fetuses with positive end-diastolic velocities in the umbilical circulation. 14, 15 Since the early 2000s, attention has moved to assessment of the ductus venosus (DV) (Figures 1 and 2 ) and computerized cardiotocograph (cCTG) analysis of fetal heart rate short-term variation (STV) to guide timing of delivery in FGR (Figure 3) . 16 A longitudinal observational study of FGR fetuses monitored by Doppler and cCTG showed that <32 weeks' gestation, DV Doppler abnormalities (Figure 4 ) in some cases preceded the onset of a low STV, and that continuing pregnancy until the cCTG becomes abnormal in these cases was associated with a significantly higher perinatal mortality and worse composite perinatal outcome. 17 In particular, mortality was higher if both DV and cardiotocography (CTG) were abnormal than when only one was abnormal. Another multicenter study on a large cohort of FGR pregnancies followed up longitudinally also demonstrated that intact survival increased by 1-2% for every extra day spent in utero up to 32 weeks. 18 The balance in early-onset FGR is between, on the one hand, prolonging pregnancy to reduce prematurity-related complications, and in the other, timely intervention, to prevent mortality and limit morbidity.
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FIGURE 1
Computerized cardiotocography readout One-hour recording of the fetal heart rate (FHR) with computerized Dawes and Redman analysis. Bullet point 8 in the figure shows short-term variation used in the Trial of Umbilical and Fetal Flow in Europe as the cardiotocography criterion for deciding upon delivery in severe fetal growth restriction.
FHR, fetal heart rate; IVC, inferior vena cava; SVC, superiro vena cava; toco, tocography.
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The issue of how to monitor and when to deliver in early-onset FGR has until recently been informed by little evidence. Indeed, in a seminal opinion 15 years ago the inconsistencies in management of severe FGR with different monitoring strategiesebiophysical profile, venous Doppler, and fetal heart rate changesewere highlighted. 7 The Trial of Umbilical and Fetal Flow in Europe (TRUFFLE) was designed to answer the question of which methodologies should be used to monitor and according to which criteria deliver fetuses with early-onset FGR. 22 In doing so, the TRUFFLE study compared 2 techniques in the monitoring and timing of delivery in early-onset (26-32 weeks) FGR. These were DV Doppler and cCTG from which the fetal heart STV can be ascertained. Both abnormalities of DV and cCTG-STV have been found to be closely associated with fetal hypoxia/ acidemia.
17, [23] [24] [25] Given expert uncertainty on the ideal trigger for intervention, the DV Doppler group was split into 2 arms: less severe (early) and more severe (late) abnormalities. In the 2 Doppler DV groups, safety-net criteria were used to trigger delivery based on the finding of very low cCTG-SVT. The presence of spontaneous, repetitive decelerations on CTG and/or deteriorating maternal condition prompted delivery in all 3 groups. After 32 weeks gestational age, pregnancy was managed according to local protocols. 26 In this review we will discuss the study design and results with relevance to their implementation in clinical practice.
The definition of early-onset FGR As smallness of the fetus can be constitutional, due to fetal malformations, chromosomal abnormalities, and infections, 19, 20 the population in the TRUFFLE study was restricted to impaired fetal growth considered to be of uteroplacental origin. The inclusion criteria were singleton pregnancies with fetal abdominal circumference (AC) <10th percentile, gestational age between 26 þ0 -31 þ6 weeks, and UA Doppler pulsatility index >95th centile. 22, 26 The American Congress of Obstetricians and Gynecologists and Royal College of Obstetricians and Gynecologists definition of growth restriction is based only on AC or estimated fetal weight (EFW) <10th percentile. 21, 27 This definition includes patients with failure of growth not dependent on uteroplacental function and thus includes also fetuses with smallness not directly related to placental insufficiency. 19, 20 In the TRUFFLE study, the definition of AC <10th percentile and umbilical impedance >95th percentile was arrived at through expert consensus of the investigator group in 2002. This has stood the test of time and with minor variation represents the combination of parameters that are closely related to perinatal morbidity (PORTO) 28 and a recent Delphi consensus (Delphi refers to the process by which expert opinion is focused towards a conclusion in a stepwise, iterative way). 29 The 26 þ0 and 31 þ6 weeks' range was chosen as representing where maximum uncertainty existed, given uncertainty of outcomes at gestational ages <26 weeks and with a fetal weight <500 g and the low incidence of severe neonatal complications 32 weeks of gestation. 30 
Monitoring techniques and criteria for delivery
The standard of care in maternal-fetal medicine units in Europe formed the basis of management for the study. Given the lack of a universally accepted protocol for monitoring these pregnancies and criteria for timing delivery, the aim of TRUFFLE was to compare the outcome in the survivors of FGR pregnancies at 2 years of age when the timing of delivery was based on different monitoring techniques, namely cCTG-STV or DV Doppler.
The cCTG (Figure 1 ) reflect changes in fetal sympathetic, parasympathetic activity and chemoreceptors occurring during the process of hypoxic deterioration in placental FGR. 23, 24 The increase in DV pulsatility index with progression to absent and reverse flow velocities of the a-wave (atrial contraction) (Figures 2 and 3 ) is typically seen only in severe and early gestational age FGR fetuses .
16,18,31,32 After 32 weeks, abnormal CTG (late decelerations, reduced variability) will almost invariably precede DV abnormalities. 16 Hypoxemia and acidemia result in altered sympathetic and parasympathetic activity, hence in decreased fetal heart rate variation, reflected by a lower cCTG-STV. 23, 24 Late (shallow) decelerations are indicative of a chemoreceptor-mediated response to fetal acidemia and of a direct depression effect of acidemia on myocardial tissue. 25 
Randomization arms
Patients were randomized into 3 arms for the decision to deliver: weeks. Spontaneous repeated persistent decelerations on CTG represented a safety-net criterion in all 3 trial arms. At gestations >32 weeks, the policy for delivery was based on local protocols. RED in the UA was recommended as a reason to deliver the fetus >32 weeks but was permissible >30 weeks; AED, >34 weeks but permissible >32 weeks.
Maternal indications for delivery
Maternal indications for delivery were considered as independent of fetal condition, randomization arm, and gestational age.
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Primary outcome Given the high rate of perinatal survival even in early preterm infants, the primary outcome was not based on perinatal mortality and morbidity. Instead, the study was powered on a primary outcome of survival without cerebral palsy or neurosensory impairment, or with a Bayley III developmental score 33 of >85, at 2 years of age.
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Secondary outcomes Secondary outcomes were perinatal mortality, and neonatal and infant morbidity and mortality.
Patient characteristics
The TRUFFLE study cohort consisted of 511 women recruited of 542 eligible for study inclusion. The mean maternal age was 31 years, 63% were nulliparous, 84% were Caucasian, with a mean body mass index of 25 kg/m 2 . No differences in demographic features were reported in the 3 trial arms. Hypertensive disorders of pregnancy were either already present at recruitment or developed during the observational period in 50% of cases with no difference between the 3 randomization arms 26 and complicated 73% of the pregnancies by the time of delivery. Comparing these data with the incidence of pregnancy hypertension, chronic hypertension, and preeclampsia in the general population, 34 it was apparent that the population entering the TRUFFLE study was destined for uteroplacental impairment from an early gestational age. Hypertensive disease, preeclampsia, and severe FGR is strongly associated with abnormal uterine artery Doppler velocimetry, although this parameter was not required for study inclusion.
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Results: fetal and neonatal risks of early FGR Mortality The mean gestational age at delivery was 30.7 weeks and neonatal weight was 1019 g. 22 Antenatal death occurred in 12 cases (2.4%), including 5 cases where parents declined consent to delivery. In spite of the severity of FGR, 92% babies survived to discharge. These results are more favorable than those previously reported from observational studies.
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Morbidity Severe morbidity among live births was present in 24% of infants and 5% of neonates died in the perinatal period.
Overall, 71% of survivors were discharged from the neonatal wards without severe morbidity. The most common causes of early neonatal morbidity were sepsis (18%) and bronchopulmonary dysplasia (10%). Relatively infrequent were germinal matrix hemorrhage (2%) and cystic periventricular leukomalacia (1%). 26 
2-year Survival and neurodisability
Of all women recruited to the study, there were nonsignificant differences in survival without infant neurodisability at 2 years: 77% for the cCTG group, 84% for the early DV group, and 85% for the late DV group (P ¼ .09); this analysis included all deaths. However, among the survivors in a predefined primary analysis, the percentage of infants without neurodevelopmental impairment at 2 years of age, corrected for prematurity, was significantly higher (95%) in the late DV group compared to the cCTG arm (85%). In the same arm (late DV changes, ie, 0 or reversed a-wave) the better neurological outcome was associated with a small and nonsignificant excess of antenatal deaths. 26 Middle cerebral artery Doppler and outcome Normalized for gestation using z-scores, middle cerebral artery (MCA) pulsatility index and umbilicocerebral ratio at inclusion were associated with 2-year survival with normal neurodevelopmental outcome (odds ratio [ 
Safety-net deliveries <32 weeks
The TRUFFLE protocol applied up to 32 weeks. In those delivered <32 weeks, the safety-net criteria triggered delivery in 38% of cases: 52% of 106 cases in the late DV group, 37% of 99 cases in the early DV group, and 25% of 105 cases in the cCTG-SVT group. Other fetal or maternal indications accounted for 30% of all deliveries <32 weeks. 37 
FIGURE 3 Ductus venosus Doppler velocimetry waveforms
Progression (from top to bottom) from increased pulsatility index (PI), to absent and reversed flow during a-wave. Positive (forward) and negative (reversed) flow are denoted. 
Discussion
The TRUFFLE findings in context Overall, outcomes for very preterm fetuses with FGR were much better than previously assumed: 82% of children with known outcome survived without neurological impairment. With the exception of cerebral ultrasound abnormalities, commonly used neonatal morbidity criteria are poor markers of later neurodevelopmental outcome. Indeed, 2-year neurodevelopmental impairment was not preceded by any component of composite neonatal morbidity in 56% of cases. 38 Gestational age at both study entry and delivery were strongly related to morbidity and mortality. Thus, specific morbidity/mortality tables in relation to gestational age at entry in the study and gestational age at delivery can be used for accurate parental counseling. The most important independent determinants of the composite adverse outcome (death or severe morbidity) were the presence of maternal hypertensive disease, low gestational age, and a low EFW at study inclusion.
Implications for clinical practice
Optimal timing of delivery of the early FGR fetus is achieved by monitoring with both DV and cCTG-STV. In those randomized to the late DV group there was better neurological outcome in surviving children, with nonsignificantly higher antenatal mortality. The latter was unlikely to be due to the lower cCTG -STV safety-net criteria in the DV randomization arm compared to those of the cCTG arm, as in 6 of the 7 cases fetal death would have been inevitable even had they been allocated to another randomization arm. Hence, delivery should be undertaken when the a-wave in the DV reaches the 0 line (absent a-wave) or when there is a pathologically low STV. This lower cCTG-STV cut-off was chosen assuming that STV of 2.6 milliseconds is the lowest cut-off clinically appropriate given the high chance of hypoxemia/acidemia below this level. 24, 39 The presence of spontaneous, repetitive fetal heart rate decelerations or maternal indications should trigger delivery independently of DV and cCTG-STV evaluation. Monitoring frequency of DV Doppler evaluation and cCTG was not established by the study, however it is reasonable to suggest frequent monitoring of cCTG and DV Doppler with a sliding scale from at least every 2-3 days to daily, based on the severity of FGR and UA Doppler abnormalities.
A subanalysis of babies delivered <32 weeks' gestation, in other words those whose management was strictly defined by the protocol, showed that more than one third delivered based on safety-net criteria, and another one third for other fetomaternal reasons. 38 Hence, in clinical practice, a significant proportion of fetuses will be delivered because of cCTG-STV abnormalities, even before DV changes occur. However, overall data from the TRUFFLE trial 22, 26 and subanalyses 37 show a better outcome by the integrated use of both DV and cCTG-STV.
Variability of measurements
There is considerable biological variation in Doppler measurements and we did not formally assess this in the TRUFFLE study. Our recommendation is that Doppler measurements should be performed by experienced clinicians and the pulsatility index should be repeated at least 3 times at each assessment to verify uniformity of findings. It is still a subject of a debate as to whether maternal steroid administration to promote fetal lung maturation affects UA Doppler (pseudonormalization of absent flow in the UA) 40 and fetal heart rate. The day-to-day risk of an abnormally low cCTG-STV prompting delivery was 5%, and not predictable by the previous cCTG-STV. 41 TRUFFLE used 2 different cut-offs: in the cCTG arm (STV <3.5 and 4 milliseconds at <29 and 29-32 weeks, respectively) and as a safetynet in the DV arm (STV <2.6 and 3.0 milliseconds at <29 and 29-32 weeks, respectively). 26 Although not mandated by the protocol, the majority of participating centers undertook daily CTG monitoring. In the case of maternal hypertension and/or HELLP syndrome, we advise repeating assessments more frequently, since fetal deterioration may occur very rapidly.
Delivery >32 weeks Although the TRUFFLE study stopped recruiting at 32 weeks, many of the pregnancies continued beyond that gestation, if the criteria for delivery were not yet met. TRUFFLE did not investigate which Doppler criteria should be used for delivering these fetuses. However, Doppler evaluation of the UA becomes increasingly more important with advancing gestation. RED flow may always prompt delivery >32 weeks and AED >34 weeks. Beyond 34 weeks it is unusual to observe an AED pattern and delivery is often then triggered by other fetal criteria. From these gestational ages 
Fetal central venous circulation
Fetal central venous circulation: highly oxygenated blood coming from placenta reaches liver through umbilical (Umb) vein. About 40% is shunted directly to heart through ductus venosus (DV); the rest is directed to the right liver lobe. DV, left hepatic vein (LHV), and right hepatic vein (RHV) drain into inferior vena cava (IVC). Highly oxygenated blood in DV forms jet streaming preferentially from right to left atrium through foramen ovale (FO), and through left ventricle and ascending aorta (Ao Asc) to fetal brain.
ajog.org Expert Reviews decisions as to the timing of delivery will take into account the maternal condition, fetal growth, and EFW and should be left to the clinical judgment of the managing team. Given the current interest in the fetal adaptive response to chronic hypoxemia assessed by Doppler of the MCA pulsatility index and its ratio with the UA (cerebroplacental ratio), 42 we undertook a secondary analysis of MCA Doppler in the TRUFFLE cohort. MCA Doppler did not add useful information for clinical management of these pregnancies. 36 
Conclusion
The optimal management of early FGR fetuses should integrate clinical, Doppler, and cCTG parameters to ensure safe deferral of delivery for the fetus and the mother, or a timely intervention. 43 Centers formerly acting upon cCTG-STV alone should be aware that severe anomalies in the DV, when they precede cCTG abnormalities, are an indication for undertaking delivery. Alternatively, when the DV is still normal, they can confidently defer delivery, provided the cCTG-STV remains above the safety-net cut-off level. NoncCTG assessment does not allow an objective assessment of fetal heart rate variability and, although its utility was not tested in this study, is not recommended for this reason. Although TRUFFLE did not specifically investigate monitoring frequency, cCTG-STV and Doppler of UA and DV should be undertaken with increasing frequency after the onset of AED in the UA, with more intensive monitoring in case of rapid deterioration. In summary, a predefined and agreed-upon protocol, based on or similar to that of TRUFFLE, 22 is likely to lead to optimal perinatal and infant outcome.
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